Back
Day Range
$22.00
$22.00
52-Week Range
$14.87
$28.06
Volume
400
50D / 200D Avg
$20.56
/
$22.44
Prev Close
$22.00
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.5 | 0.2 |
| P/B | 0.0 | 3.0 |
| ROE % | 2.0 | 3.6 |
| Net Margin % | 1.1 | 3.8 |
| Rev Growth 5Y % | 2.2 | 9.9 |
| D/E | 0.6 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$183.03
$179.43 – $186.18
|
272.30B | 1 |
| FY2027 |
$115.41
$113.14 – $117.40
|
259.01B | 1 |
| FY2026 |
$116.47
$114.18 – $118.47
|
248.89B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-09 | $265.11 | $0.61 | -99.8% |
| 2025-11-11 | $0.11 | $0.17 | +52.4% |
| 2025-08-08 | $0.02 | -$21.07 | -93815.0% |
| 2025-05-15 | -$0.06 | $0.00 | +93.1% |
| 2025-02-07 | $0.13 | $0.40 | +222.9% |
| 2024-11-08 | $0.07 | -$0.12 | -275.2% |
| 2024-08-08 | -$0.14 | $0.02 | +113.7% |
| 2024-05-10 | $0.20 | -$0.49 | -341.0% |
Dividend History
7 yr streakYield
0.06%
Payout Ratio
2.59%
Growth (3Y)
-3.97%
Growth (5Y)
-4.86%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 31, 2026 | May 01, 2026 | $0.40 | 3.70% |
| Sep 30, 2025 | Dec 12, 2025 | $0.42 | 3.52% |
| Mar 31, 2025 | May 27, 2025 | $0.42 | 5.68% |
| Sep 30, 2024 | Dec 12, 2024 | $0.43 | 5.29% |
| Mar 28, 2024 | May 28, 2024 | $0.42 | 4.36% |
| Sep 28, 2023 | Dec 12, 2023 | $0.41 | 5.23% |
| Mar 30, 2023 | May 30, 2023 | $0.47 | 4.97% |
| Sep 29, 2022 | Dec 12, 2022 | $0.43 | 4.75% |
| Mar 30, 2022 | May 31, 2022 | $0.52 | 4.08% |
| Sep 29, 2021 | Dec 10, 2021 | $0.55 | 5.39% |
| Mar 30, 2021 | Jun 18, 2021 | $0.85 | 5.47% |
| Sep 29, 2020 | Dec 10, 2020 | $0.47 | 4.43% |
| Mar 30, 2020 | Jun 02, 2020 | $0.60 | 4.96% |
| Sep 27, 2019 | Dec 03, 2019 | $0.60 | 4.73% |
| Mar 27, 2019 | May 31, 2019 | $0.59 | 4.62% |
| Sep 26, 2018 | Dec 04, 2018 | $0.58 | 4.15% |
| Mar 28, 2018 | Jun 01, 2018 | $0.61 | 3.02% |
| Sep 27, 2017 | Dec 04, 2017 | $0.58 | 2.45% |
| Mar 29, 2017 | Jun 05, 2017 | $0.51 | 2.25% |
| Sep 28, 2016 | Dec 02, 2016 | $0.57 | 2.19% |
Key Takeaways
Revenue grew 2.17% annually over 5 years — modest growth
ROE of 1.97% is below average
Generating 11.65B in free cash flow
P/E of 0.45 — trading at a low valuation
Cash machine — converts 421.95% of earnings into free cash flow
Capital efficient — spends only 4.24% of revenue on capex
Growth
Revenue Growth (5Y)
2.17%
Revenue (1Y)2.56%
Earnings (1Y)N/A
FCF Growth (3Y)3.63%
Quality
Return on Equity
1.97%
ROIC0.88%
Net Margin1.14%
Op. Margin1.09%
Safety
Debt / Equity
0.63
Current Ratio1.72
Interest Coverage4.47
Valuation
P/E Ratio
0.45
Forward P/E0.19
P/B Ratio0.01
EV/EBITDA17.81
Dividend Yield0.06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2.56% | Revenue Growth (3Y) | -3.49% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | -58.03% |
| Revenue Growth (5Y) | 2.17% | Earnings Growth (5Y) | -36.95% |
| Profitability | |||
| Revenue (TTM) | 243.03B | Net Income (TTM) | 2.76B |
| ROE | 1.97% | ROA | 0.99% |
| Gross Margin | 27.65% | Operating Margin | 1.09% |
| Net Margin | 1.14% | Free Cash Flow (TTM) | 11.65B |
| ROIC | 0.88% | FCF Growth (3Y) | 3.63% |
| Safety | |||
| Debt / Equity | 0.63 | Current Ratio | 1.72 |
| Interest Coverage | 4.47 | ||
| Dividends | |||
| Dividend Yield | 0.06% | Payout Ratio | 2.59% |
| Dividend Growth (3Y) | -3.97% | Dividend Growth (5Y) | -4.86% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 0.45 | Forward P/E | 0.19 |
| P/B Ratio | 0.01 | P/S Ratio | 0.01 |
| PEG Ratio | -0.34 | Forward PEG | N/A |
| EV/EBITDA | 17.81 | Fwd EV/EBITDA | 1.40 |
| Forward P/S | 0.01 | Fwd Earnings Yield | 526.32% |
| FCF Yield | 932.00% | ||
| Market Cap | 1.25B | Enterprise Value | 47.02B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 243.03B | 236.95B | 260.91B | 272.94B | 223.02B |
| Net Income | 2.76B | -7.55B | 15.68B | 29.60B | 17.47B |
| EPS (Diluted) | 48.59 | -132.77 | 275.49 | 519.42 | 306.32 |
| Gross Profit | 67.20B | 63.24B | 89.92B | 111.80B | 76.21B |
| Operating Income | 2.64B | -4.04B | 23.38B | 50.49B | 25.39B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 279.58B | 290.85B | 297.92B | 286.59B | 252.75B |
| Total Liabilities | 142.29B | 148.34B | 147.88B | 146.41B | 137.45B |
| Shareholders' Equity | 137.11B | 142.51B | 150.05B | 140.18B | 115.31B |
| Total Debt | 86.65B | 81.95B | 77.16B | 73.00B | 80.46B |
| Cash & Equivalents | 40.89B | 39.95B | 44.19B | 46.49B | 42.96B |
| Current Assets | 119.14B | 123.22B | 131.85B | 132.54B | 118.01B |
| Current Liabilities | 69.44B | 64.07B | 64.37B | 70.76B | 62.92B |